|
HS Code |
573100 |
| Product Name | 4-(chloromethyl)pyridine hydrochloride (1:1) |
| Chemical Formula | C6H7Cl2N |
| Molecular Weight | 164.04 g/mol |
| Cas Number | 85118-18-9 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 147-151 °C |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Storage Temperature | Store at 2-8 °C |
| Synonyms | 4-Picolyl chloride hydrochloride, 4-(Chloromethyl)pyridine hydrochloride |
| Hazard Statements | Causes skin and eye irritation |
As an accredited 4-(chloromethyl)pyridine hydrochloride (1:1) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g amber glass bottle, securely sealed, labeled with product name "4-(chloromethyl)pyridine hydrochloride (1:1)", chemical formula, and safety warnings. |
| Container Loading (20′ FCL) | 20′ FCL: Chemical packed in 25 kg drums, 400 drums per container (10 MT net weight), securely loaded for export. |
| Shipping | 4-(Chloromethyl)pyridine hydrochloride (1:1) is shipped in secure, sealed containers to prevent moisture exposure and degradation. The packaging conforms to regulations for hazardous chemicals, ensuring safe transit. It is classified under UN hazard guidelines and must be kept tightly closed and stored in a cool, dry place during shipment. |
| Storage | 4-(Chloromethyl)pyridine hydrochloride (1:1) should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers and moisture. Protect from light and avoid extreme temperatures. Follow all relevant safety and regulatory guidelines when storing this substance to ensure chemical stability and prevent hazardous exposure. |
| Shelf Life | 4-(Chloromethyl)pyridine hydrochloride typically has a shelf life of 24 months when stored in a cool, dry, and sealed container. |
|
Purity 98%: 4-(chloromethyl)pyridine hydrochloride (1:1) with 98% purity is used in pharmaceutical intermediate synthesis, where it ensures high reaction yield and minimal impurity formation. Melting Point 156°C: 4-(chloromethyl)pyridine hydrochloride (1:1) with a melting point of 156°C is utilized in organic synthesis processes, where it provides enhanced thermal stability during reagent handling. Molecular Weight 164.06 g/mol: 4-(chloromethyl)pyridine hydrochloride (1:1) of molecular weight 164.06 g/mol is applied in fine chemical manufacturing, where precise stoichiometric calculations are required for accurate formulation. Moisture Content <0.5%: 4-(chloromethyl)pyridine hydrochloride (1:1) with moisture content below 0.5% is employed in agrochemical production, where it reduces risk of hydrolysis and degradation of active ingredients. Solubility in Water: 4-(chloromethyl)pyridine hydrochloride (1:1) exhibiting high solubility in water is used in aqueous reaction systems, where it ensures homogeneous mixing and efficient molecular interaction. Stability at 25°C: 4-(chloromethyl)pyridine hydrochloride (1:1) stable at 25°C is used in long-term storage of chemical inventories, where it maintains consistent reactivity over time. Particle Size <50 µm: 4-(chloromethyl)pyridine hydrochloride (1:1) with particle size less than 50 micrometers is applied in catalyst preparation, where fine dispersion optimizes surface contact and reaction rates. |
Competitive 4-(chloromethyl)pyridine hydrochloride (1:1) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Day after day, our production lines turn out batches of 4-(chloromethyl)pyridine hydrochloride (CMHP HCl) under strict process controls. In this industry, consistency does not just count as a buzzword; every lot has to pass analytical checks that align with the real work chemists perform in the field. CMHP HCl, which we commonly designate as Model CMH-Py-HCl-99, finds its way into research labs and fine chemical plants around the world. Manufactured through carefully managed chloromethylation, our process has evolved as customer feedback informs every tweak — from reaction times to purification steps.
Unlike generic monohydrochloride salts based on pyridine, 4-(chloromethyl)pyridine hydrochloride holds a unique structural niche. The chloromethyl group sits on the fourth carbon, delivering targeted reactivity that’s different from isomers such as the 2- or 3-variants. This makes CMHP HCl more than just another specialty intermediate; it serves a crucial role in the development of pharmaceutical building blocks, catalysts, and functionalized materials for advanced applications.
Through more than a decade of production, we have witnessed scientists using this compound in Suzuki couplings, nucleophilic substitution reactions, and in the stepwise synthesis of N-heterocyclic compounds. Demand spikes often match breakthroughs in new drug candidates, showing the importance of pure, well-characterized CMHP HCl as both a research staple and a scale-up intermediate.
We focus on specifics that mainstream suppliers sometimes overlook. Model CMH-Py-HCl-99 maintains a minimum purity of 99% (HPLC), offering a solid melting point of around 196°C. This is not just a number; higher purity means fewer byproducts to muddy downstream syntheses. Chemists have described how a trace impurity or two can compromise a reaction sequence worth weeks of work. Our customers frequently tell us that material from trader-oriented supply chains fails tighter QC screening, often leading them back to the source.
Moisture content is controlled to less than 0.3%, as measured via Karl Fischer titration. Residual solvents, often an issue with poorly controlled crystallization and washing, are analytically minimized; GC analysis sees values under 200 ppm for common process solvents. Each batch ships with a full analytical breakdown, not just a perfunctory purity tick box, but a record of residuals, trace ions, and even elemental analysis on request.
Our customers rarely use CMHP HCl directly without modifying or incorporating it into a value-added compound. Medicinal chemistry teams often look for it as an alkylating agent that stays manageable and clean, providing a predictable starting point for creating N-heterocycles and tethered ligands. Some big pharma process chemists tell us that other suppliers’ lots can match paper specs, but inconsistencies show up in critical stages — particularly during late-stage scale-ups. Reactor fouling, variable drying times, and batch-to-batch discoloration have all been traced to differences in salt purity and crystal form.
To address these very real frustrations, we run a dedicated filtration and drying line, using GMP-inspired hygiene and traceability. Crystals are thoroughly washed and dried under anhydrous conditions before packing in HDPE containers under nitrogen. This basic but essential measure keeps the hydrochloride salt free of environmental moisture and airborne contaminants, delivering product with a crisp, white appearance and reliable flow for automated dispensing.
Industry tradition lumps pyridine derivatives into broad categories, but specific substitution patterns and salt forms make a world of difference. The hydrochloride salt offers several benefits over the free base (CMHP), not just in handling but in safety and storage. Free bases are typically more volatile and may darken due to light or oxygen exposure. In contrast, the hydrochloride salt exhibits thermal stability, resistance to hydrolysis, and less odor, reducing both environmental and operator concerns.
Competing products often come as technical grades designed for bulk agricultural use or as analytical standards. These can carry unknown residuals, suffer from unstable flow, and sometimes display brownish or yellow tints. In a scaled reaction — for example, when synthesizing new kinase inhibitors or custom catalysts — these defects can translate into wasted time and suboptimal yields. Our tight control over crystallization, washing, and packing comes straight from customer requests and internal process reviews. We’ve shut down entire lines to resolve issues traced to trace iron or heavy metals picked up in outdated glassware or poorly maintained equipment.
Model CMH-Py-HCl-99 started as a response to R&D requests for higher-assay material that did not compromise on handling safety. Unlike the free base, which can be oily or sticky, the hydrochloride form produces a manageable crystalline powder. That feature alone simplifies measurement for automated or manual charging in multi-kilo reactors.
Some customers still request the 2-(chloromethyl)pyridine or 3-(chloromethyl)pyridine isomers, but those behave quite differently in both storage and reaction sequences. The para-substituted CMHP HCl (model CMH-Py-HCl-99) is less likely to produce unwanted side reactions in multi-step syntheses aimed at pharmaceutically active compounds. Process engineers point out that para-substitution avoids issues in metal-catalyzed couplings and enables higher specificity in nucleophilic substitutions.
Our plant’s synthesis route for CMHP HCl avoids traditional nitro reduction or uncontrolled methylation chemistry. Chloromethylation steps leverage closed-system technology for operator safety and environmental responsibility. By-products and emissions are captured and recycled. This aligns with broader industry and regulatory trends, where procurement teams consistently ask for documentation and transparency in sourcing and process safety.
Environmental requirements around pyridines and haloalkyl derivatives grow stricter each year. We keep a close eye on both batch process releases and final product purity. Going beyond ordinary “in spec” thinking, we invest in upstream filtration, continuous washing, and waste minimization. Only a handful of global manufacturers can accommodate such feedback loops as quickly as we do. This discipline enables both smaller research projects and larger-scale GMP process development to focus on science rather than troubleshooting chemical reliability.
Safety is not an afterthought. Whether supplying to startups or Fortune 500 labs, we field questions on packaging, residual solvents, and shipment documentation every week. Our in-house safety team audits every product before approval, with an eye toward both regulatory compliance and frontline usability. For CMHP HCl, no shipment leaves our factory without certificates confirming batch-specific analytical results.
Trust builds from transparency, and transparency starts from origin. We maintain lot-level traceability on every kilogram of CMHP HCl, pairing digital records with physical QC samples. Inventory moves via sealed, tamper-evident packaging, with inspection points built into standard operating procedures. Many downstream users conduct independent third-party analyses before accepting significant shipment volumes; our QC results routinely match or outperform these outside results.
This extra level of detail helps avoid the headaches — spoiled runs, off-spec product, or paperwork gaps — that can compromise complex synthesis campaigns. Our team schedules regular collaborative audits with key partners, exposing our full process flow for review. This confidence, grounded in day-to-day production experience, gives research teams and commercial buyers real assurance that quality won’t slip as batch volumes grow.
We supply CMHP HCl to a spectrum of customers — drug development outfits, specialty chemical startup teams, university labs, and established industrial formulators. Each group brings a specific set of requirements. For small molecule synthesis, academic and contract research staff want reliable reactivity and sample uniformity, supported by analytical documentation that meets publication or audit standards. Our internal chemists work with these groups to optimize not just the purity spec, but the physical form, particle size, and even packaging formats.
Scale-up teams in pharmaceutical manufacturing focus on another set of issues. Large batches demand tighter controls over moisture, flowability, and contamination. In-process testing for cross-contamination with other pyridines or halogenated species often leads to further scrutiny of received inventory. Our regular process reviews and feedback-driven modifications help us match these needs — not through theoretical improvements, but through day-to-day operational discipline.
Some synthetic routes rely on semibulk production. For these projects, we run custom batch campaigns, offering extra isolation, filtration, or drying steps as required. This is typically more than just an option; it is a necessity when regulatory filings or customer-developed analytical methods dictate acceptance criteria outside the normal bounds. This adaptability sets manufacturer-supplied product apart from reseller or general distributor offerings.
The demand for 4-(chloromethyl)pyridine hydrochloride does not stay static. Research advances, new regulatory decisions, and changing procurement practices all push our operation to stay flexible. Just a few years ago, demand ran largely through academic and contract labs. Today’s uptick in biologically active compound discovery feeds larger orders and requests for kilogram and multi-kilogram batches — sometimes with timelines of days, not weeks.
Anticipating these cycles, we built extra reactor capacity and paired it with automated monitoring and digital recordkeeping. Months of direct feedback revealed just how quickly a sluggish lot or a storage query could lead to project delays. Now, inventory management and shipment coordination are not mere logistics work but vital links in the manufacturing chain.
Supply chain interruptions can disrupt research timelines and commercial production. As the manufacturer, we keep in stock enough buffer material for repeat runs and rapid resupply. Our logistics partners come vetted for temperature handling and transit tracking, which cuts down on delays and damaged shipments. Packaging improvements, such as nitrogen-flushed bottles and additional secondary containment, stem from years of customer input — particularly from export-oriented buyers facing long transit times or unpredictable customs checks.
Feedback shapes the course of our operation every year. Even minor improvements, like more secure bottle labeling or enhanced lot tracking, spark operational changes if they matter to customers. Shipping delays caused by improper documentation or mismatched customs codes have led us to revamp how paperwork travels alongside every CMHP HCl lot. Similarly, changes in solvent use or reaction workup steps originated not from regulatory pressures but from the hands-on experience of working chemists who flagged critical issues with usability, recovery, or process cleanliness.
Stability testing is another area that has benefited from this hands-on approach. Our QC labs review retained samples at intervals, charting any changes in color, melting point, or analytical profile over time. This practice is crucial for chemists planning long-term storage or repeated use. Our in-house guidance, which stems from these stability records, keeps users informed so that their critical syntheses don’t suffer from overlooked degradation or caking.
Manufacturers of complex chemicals can sometimes lose sight of the challenges faced in the field. By keeping our technical and production teams in direct contact with users, we turn abstract requirements into actionable production goals. For CMHP HCl, this has meant iterative adjustments to crystallization regimes and regular side-by-side testing against competitor products. Delays in field results, difficult filtrations in scale-up, or unexpected regulatory hurdles push us to keep learning and improving.
Over the years, we’ve collaborated with academic labs on new reaction conditions and helped commercial partners troubleshoot failed loads attributed to out-of-spec pyridine salts from outside sources. Frequently, our direct factory shipments have outperformed commodity-grade offerings by avoiding hidden carry-overs, erratic moisture loads, or unpredictable aging.
As the chemical industry grows, the line between fine and commodity chemical production continues to blur. Companies seeking premium products no longer just look for paper specifications; they’re demanding evidence of process discipline, analytical transparency, and shipment security. Our approach — investing in people and process control — keeps us positioned to support those who require more than basic compliance.
Modern chemical manufacturing calls for more than reliable chemistry. Global supply chains, emerging regulations, and ongoing customer demands make adaptability and technical engagement essential. We keep a steady eye on both what happens in the lab and what requirements buyers bring to the table.
4-(Chloromethyl)pyridine hydrochloride (1:1) will remain a mainstay in pharmaceutical synthesis and beyond. By staying out front on analytical, packaging, and process requirements, we ensure researchers, process engineers, and procurement teams rely on practical experience as much as documentation. Our role is not limited to product delivery; it includes solving emerging challenges, maintaining traceable records, and building a safety culture that supports chemists where it counts — at the bench, on the plant floor, and in the planning room.